February 11, 2026

Merck and Calla Lily partner to advance Callavid platform

​Merck and Calla Lily Clinical Care have announced a strategic partnership to advance Callavid, an intravaginal drug delivery platform.The post...

February 11, 2026

BioRestorative concludes Phase II BRTX-100 trial enrolment for cLDD

​BioRestorative Therapies has concluded patient enrolment in its Phase II study evaluating the efficacy and safety of BRTX-100 for cLDD.The...

February 11, 2026

Insilico and CMS launch drug discovery collaborations for CNS diseases

​Insilico Medicine has announced several AI drug discovery collaborations with CMS across several projects in CNS and autoimmune diseases.The post...

February 10, 2026

TransMedics receives IDE approval from FDA for OCS Heart trial

​TransMedics Group has received full and unconditional IDE approval from the US FDA for its next-generation OCS ENHANCE Heart trial.The...

February 10, 2026

Veradermics concludes enrolment in second Phase III VDPHL01 trial

​Veradermics has completed enrolment in its second pivotal Phase III clinical trial of VDPHL01 for male pattern hair loss treatment.The...

February 10, 2026

Takeda and Iambic announce $1.7bn deal to advance small molecule programmes

​Takeda has entered into a multi-year partnership to utilise Iambic’s AI drug discovery models for advancing small molecule programmes, in...

February 9, 2026

Abbott reports positive VERITAS study results for AFib

​Abbott has reported positive early data from the VERITAS study, evaluating its investigational Amulet 360 LAA occluder, designed to lower...

February 9, 2026

Genentech reports fenebrutinib Phase III results for PPMS

​Genentech has reported new data from the Phase III FENtrepid trial of fenebrutinib, an investigational Bruton’s tyrosine kinase inhibitor, for...

February 9, 2026

Novartis starts construction on new research facility in San Diego, US

​Novartis has commenced construction on its new global Biomedical Research centre in San Diego, California, US, aimed at expanding its...

Connect with us

Whether you are a professional looking for a new job or a representative of an organization who needs workforce solutions - we are here to help.